Practical Cardiology

12/25/2023

Catch up on the latest in by heading over to our cardiology resource center.

The cardiology condition center is a comprehensive resource for clinical news and expert insights on cardiology. Read more at HCPLive.

11/11/2023

Get caught up on SELECT data, including a new expert-led podcast episode, over on our conference coverage page!

https://www.hcplive.com/conference/aha

10/24/2023

Earlier today, Milestone Pharmaceuticals, Inc. announced the submission of an NDA to the US Food and Drug Administration for etripamil nasal spray in the treatment of paroxysmal supraventricular tachycardia.

Learn more:
https://www.hcplive.com/view/etripamil-nasal-spray-application-submitted-fda-psvt-treatment

10/16/2023

Catch up on anything you may have missed from by heading over to our conference coverage page!

https://www.hcplive.com/conference/hfsa

HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conferen...

10/13/2023

With the recent HF Stats report as a backdrop, Alex Hajduczok, MD, of Thomas Jefferson University Hospital, discusses the importance of the latest GUIDE-HF data from .

For full video, use the link below:

Alex Hajduczok, MD, provides perspective on the new GUIDE-HF trial data presented at HFSA 2023.

10/06/2023

We are on-site in Cleveland for . Follow us and HCPLive throughout the weekend and into early next week for the latest updates in and .

https://www.hcplive.com/conference/hfsa

10/03/2023

Findings from a meta-analysis are calling attention to the viability of classification and risk stratification using greater albuminuria and decreased eGFR.

https://www.hcplive.com/view/uacr-egfr-associated-with-hospitalizations-other-adverse-outcomes

09/28/2023

A new analysis examining 2 decades of trends in the prevalence and overlap of cardiac, renal, and metabolic conditions among US adults paints a concerning picture.

https://www.hcplive.com/view/report-more-than-25-of-us-adults-has-1-or-more-cardiac-renal-or-metabolic-condition

A 20-year analysis reveals over 25% of US adults have cardiac, renal, or metabolic conditions, with disparities in age and race.

09/27/2023

Announced by Ionis Pharmaceuticals, topline results from Balance show olezarsen met the study's primary endpoint with a statistically significant reduction in triglyceride levels versus placebo.

https://www.hcplive.com/view/olezarsen-benefits-familial-chylomicronemia-syndrome-phase-3-balance-trial

Announced by Ionis Pharmaceuticals, topline results show olezarsen met the study's primary endpoint with a statistically significant reduction in triglyceride levels versus placebo.

09/21/2023

A new study is calling attention to the potential increase in risk for coronary microvascular dysfunction among patients with severe psoriasis.

https://www.hcplive.com/view/psoriasis-severity-could-signal-increased-cardiovascular-risk

09/20/2023

The USPSTF has released their latest recommendation statement, with this update focused on screening for hypertensive disorders of pregnancy.

https://www.hcplive.com/view/uspstf-updates-guidance-on-screening-for-hypertensive-disorders-of-pregnancy

In their latest recommendation statement, the USPSTF recommends blood pressure screening for all pregnant individuals to detect hypertensive disorders.

09/19/2023

In their latest recommendation statement, the USPSTF recommends blood pressure screening for all pregnant individuals to detect hypertensive disorders.

https://bit.ly/3t3cDl9

In their latest recommendation statement, the USPSTF recommends blood pressure screening for all pregnant individuals to detect hypertensive disorders.

09/14/2023

Findings from a recent study showed Fatty Liver Index was predictive of cardiovascular disease mortality among patients with a history of myocardial infarction.

Learn more:
https://bit.ly/3reyOEp

Findings showed Fatty Liver Index was predictive of cardiovascular disease mortality among patients with a history of myocardial infarction.

09/13/2023

New data from a dose-finding trial suggests the aldosterone synthase inhibitor lorundrostat could find a role in the management of resistant or uncontrolled hypertension.

https://ow.ly/aKKV50PLjiF

New data from a dose-finding trial suggests the aldosterone synthase inhibitor lorundrostat could find a role in the management of resistant or uncontrolled hypertension.

09/01/2023

At , the spotlight was on mavacamten and its role in obstructive hypertrophic cardiomyopathy.

Learn more:
https://ow.ly/k4Vr50PGRyN

A trio of studies and new guidelines presented at the ESC Congress 2023 highlight advancement in the management of hypertrophic cardiomyopathy, particularly with use of mavacamten.

08/08/2023

How might SELECT results influence the role of cardiologists in obesity management?

We asked Dr Michael Blaha, of Johns Hopkins Medicine, a recent interview.

Check out his response:
https://ow.ly/yWuS50PvftT

In a recent Q&A, Michael Blaha, MD, discusses how he views the ideal role of cardiologists in the management of obesity and how this role could change based on the results of the SELECT trial.

08/01/2023

“Low- to moderate-intensity statin therapy is associated with a greater LDL-C reduction in older than younger persons and may be more appealing as initial treatment in older adults who are at increased risk for adverse events"

https://ow.ly/ZNmF50Pq8az

An analysis of data from more than 80,000 patients using statins suggests the initial benefit on LDL-C reduction was greater for older patients than younger patients.

07/31/2023

This cardiology case report from Brady Pregerson, MD, features a patient in their late 60s presenting with multiple episodes of chest pain.

Check out the ECG and determine the correct diagnosis!

https://ow.ly/huQR50Ppsif

This cardiology case report from Brady Pregerson, MD, features a patient in their late 60s presenting with multiple episodes of chest pain. Check out the ECG and determine the correct diagnosis!

07/31/2023

ICYMI: A new analysis suggests Black patients with NICM and an ICD had a high risk and burden of arrhythmia, with a lower survival rate, compared with White patients.

https://ow.ly/fNbY50Pme5g

A new analysis suggests Black patients with NICM and an ICD had a high risk and burden of arrhythmia, with a lower survival rate, compared with White patients.

07/30/2023

Consumption of a vegetarian diet may have modest, but significant improvements in cardiometabolic outcomes beyond standard therapy in individuals with or at high risk of cardiovascular diseases, according to new research.

Learn more:
https://ow.ly/HvF050PmcjT

A meta-analysis of 20 studies suggests a vegetarian diet was associated with significant reductions in LDL-C, HbA1c, and body weight in individuals at high risk of CVDs.

07/29/2023

Data from a phase 1 proof-of-concept study provides insight into the safety, tolerability, and pharmacology of NI006 in patients with ATTR cardiomyopathy.

https://ow.ly/wZ8p50PmbOl

Data from a phase 1, first-in-human trial of NI006 suggests the agent could have a potential role in the management of transthyretin amyloid cardiomyopathy.

07/28/2023

A study from Denmark leveraging more than 40 million years of follow-up data from patients dating back to the 1950s offers insight into the apparent increase in the risk of myocardial infarction associated with pregnancy loss in women.

A study from Denmark leveraging more than 40 million years of follow-up data from patients dating back to the 1950s offers insight into the apparent increase in the risk of myocardial infarction associated with pregnancy loss in women and whether this same effect is observed in male partners.

07/27/2023

A secondary analysis of ASPREE is bringing the role of aspirin in primary prevention settings further into question, suggesting daily use of low-dose aspirin was associated with a 38% increase in intracranial bleeding in older adults.

A secondary analysis of ASPREE is bringing the role of aspirin in primary prevention settings further into question, suggesting daily use of low-dose aspirin was associated with a 38% increase in intracranial bleeding in older adults.

07/26/2023

A new analysis suggests the receipt of self-reported heart health counseling at a postpartum visit was stable or slightly declined from 2016 to 2020, despite increases in CVD risk factors.

https://ow.ly/QQuB50PmbAQ

A new analysis suggests the receipt of self-reported heart health counseling at a postpartum visit was stable or slightly declined from 2016 to 2020, despite increases in CVD risk factors.